Magenta Medical vs Amgen
Side-by-side comparison of AI visibility scores, market position, and capabilities
Magenta Medical is developing the Elevate pLVAD, the world's smallest percutaneous heart pump — FDA Breakthrough Device for HR-PCI and cardiogenic shock; raised $105M Series C in 2023.
About
Magenta Medical is an Israel-based medical device company developing a miniaturized percutaneous Left Ventricular Assist Device (pLVAD) to provide temporary mechanical circulatory support for patients with acute cardiac conditions. Founded and headquartered in Israel, the company''s flagship product, the Elevate™ heart pump, is inserted via an 8-French catheter over a guidewire — making it one of the least invasive cardiac support devices ever developed. It can deliver more than 5 L/min of hemodynamic support.
Amgen (AMGN) reported $33.4B revenue in FY2024, up 19% YoY (post-Horizon acquisition). Top-5 global biotech. 10+ blockbuster drugs. ~24,000 employees. HQ: Thousand Oaks, CA. Market cap ~$130B.
About
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologics and brought landmark medicines including Epogen, Neupogen, and Enbrel to market. The company reported revenues of $33.4B in FY2024, up 19% year-over-year, boosted by the transformational $28B acquisition of Horizon Therapeutics in October 2023.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.